Olba DVx Healthcare Co., Ltd. (2689) said its board on Sept. 29, 2026 approved the purchase of 167 of its own common shares, the fractional shares created by its share exchange with DVx Inc., at that day's Tokyo Stock Exchange closing price.
The company completed a share exchange effective Sept. 1, 2026, under which it became the wholly owning parent of DVx Inc., which became a wholly owned subsidiary. The company shares allotted to DVx shareholders in the exchange left fractions of less than one share. The board decided to purchase those fractions as treasury stock under Article 234, Paragraphs 4 and 5 of Japan's Companies Act.
The total payment will equal the 167 shares multiplied by the closing price of the company's common stock on the Tokyo Stock Exchange on the purchase date, Sept. 29, 2026. If no trade occurs that day, the price of the first trade executed on the exchange after that date will be used instead. The filing did not state a yen amount.
| Item | Detail |
|---|---|
| Share class | Common stock |
| Shares to be purchased | 167 |
| Payment basis | 167 shares × TSE closing price on purchase date |
| Purchase date | Sept. 29, 2026 |
| Legal basis | Companies Act Art. 234, Paras. 4 and 5 |
The company is listed on the TSE Standard Market. The filing was issued under the name of President and Representative Director Yohei Maejima.
The purchase date is Sept. 29, 2026, the same day as the board resolution.
| Hikari Tsushin, Inc. | |
| Offer price | ¥1,000 per common share |
| M&A / TOB | 1 |
| Guidance | 0 |
| Buybacks | 0 |
| Dividends | 0 |
| Capital | 0 |
| Earnings | 0 |
| People | 0 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理，非投資建議，亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。